【ニュース】「マンジャロ」求め来日する韓国人が急増 地方都市の病院がSNSで“聖地”に #shorts

ANNnewsCH · 2:19 · Sep 13, 2026

Key vocabulary

The words worth knowing from this video — tap one to hear it in real clips.

Listen line by line

Tap a timestamp to jump the player to that moment and hear the line as it's spoken.

  1. 中国に反乱。余計な人が打ち始めて。2週間で大きなやせたそうです

    Rebellion in China. People who shouldn't be are starting to use it. It seems they lost a lot of weight in two weeks.

    中国发生反乱。多余的人开始接种。据说两周内瘦了很多

  2. ネットなどで話題になっている抗う病治療薬マンジャロ。日本の厚生労働省からは、思わぬ健康被害の恐れもあるとして適正な使用が呼びかけられていますが

    Mounjaro, an anti-obesity drug that has become a hot topic on the internet and elsewhere. The Japanese Ministry of Health, Labour and Welfare is calling for its proper use, warning of the risk of unexpected health damage, but

    在网络等平台上成为话题的抗肥胖治疗药“替尔泊肽”(Mounjaro)。日本厚生劳动省呼吁应适当使用,因为担心可能会出现意想不到的健康损害,但

  3. とし、日本の地方都市にマンジャロを処方してくれる病院があるとしたので、さらに調べていくとそこが日本全国で一番安かったんです

    I was told there was a hospital in a regional city in Japan that would prescribe Mounjaro, so I looked into it further and found it was the cheapest in all of Japan.

    说是日本的某个地方城市有可以开替尔泊肽处方的医院,进一步调查后发现那里是全日本最便宜的

  4. そう話すのは日本の病院でマンジャロを処方してもらったという30代の女性です

    That is what a woman in her 30s who had Mounjaro prescribed at a Japanese hospital said.

    这样说的是一位在日本医院开过替尔泊肽处方的30多岁女性

  5. 当然私の年代はいませんでしたが、数人の中年女性たちが一緒に処方してもらって出ていくのを見ました

    Naturally, there was no one of my age, but I saw several middle-aged women getting prescriptions together and leaving.

    当然没有我这个年纪的,但我看到几位中年女性一起开完处方后走了出来

More Japanese listening

Practice in LingoDew

In the app, every line of this video is tappable: look a word up, save it, and review it right before you forget — with real clips, not textbook audio.

Be the first to know when LingoDew for iOS launches

LingoDew for iOS isn't on the App Store yet. Leave your email and we'll tell you the moment it ships.

Already on Android? Get it on Google Play

You're on the list! We'll email you as soon as LingoDew for iOS launches.No spam — one email about the launch, that's it.